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The ability to identify mechanisms underlying drug-induced liver injury (DILI) in man has
been hampered by the difficulty in obtaining liver tissue from patients. It has recently
been proposed that whole blood toxicogenomics may provide a non-invasive means for
mechanistic studies of human DILI. However, it remains unclear to what extent changes
in whole blood transcriptome mirror those in liver mechanistically linked to hepatotoxic-
ity. To address this question, we applied the program Extracting Patterns and Identifying
co-expressed Genes (EPIG) to publically available toxicogenomic data obtained from rats
treated with both toxic and subtoxic doses of acetaminophen (APAP). In a training set of
animals, we identified genes (760 at 6 h and 185 at 24 h post dose) with similar patterns
of expression in blood and liver during APAP-induced hepatotoxicity. The pathways rep-
resented in the coordinately regulated genes largely involved mitochondrial and immune
functions. The identified expression signatures were then evaluated in a separate set of
animals for discernment of APAP exposure level or APAP-induced hepatotoxicity. At 6 h,
the gene sets from liver and blood had equally sufficient classification of APAP exposure
levels. At 24 h when toxicity was evident, the gene sets did not perform well in evaluating
APAP exposure doses, but provided accurate classification of dose-independent liver injury
that was evaluated by serum ALT elevation in the blood. Only 38 genes were common to
both the 6 and 24-h gene sets, but these genes had the same capability as the parent gene
sets to discern the exposure level and degree of liver injury. Some of the parallel transcript
changes reflect pathways that are relevant to APAP hepatotoxicity, including mitochon-
dria and immune functions. However, the extent to which these changes reflect similar
mechanisms of action in both tissues remains to be determined.
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INTRODUCTION
Liver injury due to prescribed and over-the-counter medica-
tion use is a public health problem of increasing frequency and
importance. Drug-induced liver injury (DILI) has been linked to
nearly 1000 drugs (Abboud and Kaplowitz, 2007) and is the most
common reason for regulatory actions concerning drugs, includ-
ing failure of regulatory approval of new drugs, withdrawal of
approved drugs from the market, and limitation in use (Watkins,
2005; Fontana, 2008). DILI accounts for more than half of the
cases of acute liver failure with acetaminophen (APAP) being the
principal offending drug (Lee, 2007; Tujios and Fontana, 2011).
Study of the mechanisms underlying DILI in man has been
hampered by the general inability to obtain liver biopsies from
patients during DILI episodes. Recent investigations have sug-
gested that changes in whole blood transcriptome occur during
acetaminophen hepatotoxicity and may precede traditional serum
biomarkers in detecting and predicting this toxicity (Bushel et al.,
2007; Huang et al., 2010). In one study, in healthy volunteers, a
single 4 gram dose of APAP did not result in clinical or biochemical
evidence of liver injury but was associated with down-regulation
of genes involved in oxidative phosphorylation in whole blood
(Fannin et al., 2011). These changes were interpreted as consis-
tent with mitochondrial injury known to occur in the liver during
APAP toxicity. These observations suggested that analysis of whole
blood transcriptome could provide biomarkers that would be both
more sensitive than those used currently to detect hepatotoxic-
ity, and that could potentially provide insight into mechanisms
that underlie hepatotoxicity. A mechanistic link between liver and
blood toxicity from APAP is plausible because human and rat
lymphocytes contain many of the cofactors and enzymes impli-
cated in mechanisms of APAP hepatotoxicity, including CYP2E1,
the major enzyme metabolizing APAP into its active metabolite
NAPQI and glutathione, the major cofactor involved in detoxifi-
cation of NAPQI (Dey et al., 2005; Hannon-Fletcher and Barnett,
2008; Dhillon et al., 2011). It has also been noted that blood
lymphocyte count falls during APAP hepatotoxicity in rodents
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(Yamaura et al., 2002; Masson et al., 2007) which may result from
cytotoxicity. However, during liver injury due to APAP, it is unclear
to what extent changes in blood transcriptome mirror those occur-
ring in liver. We reasoned that the subset of genes coordinately
regulated in liver and blood during APAP hepatotoxicity would
be the most useful to pursue in terms of mechanistic investiga-
tions. In addition, we reasoned that this subset of genes might
be superior to other gene sets in the application of whole blood
toxicogenomics to detecting hepatotoxicity from APAP.
Extracting Patterns and Identifying co-expressed Genes (EPIG;
Zhou et al., 2006; Chou et al., 2007) is a transcriptome analysis
program that utilizes the underlying structure of gene expression
data to extract patterns and identify co-expressed genes that are
responsive to experimental conditions. The program groups tran-
scripts according to distinct patterns of induction or repression
without regard to pathway or function. It is an ideal program to
correlate changes in the transcriptome between two or more tis-
sues. Gene Ontology (GO) analysis of the genes in the patterns
extracted by EPIG then can identify significant categories related
to biological processes (Chou et al., 2007).
We applied EPIG to publically available toxicogenomics data
obtained in rats treated with toxic and subtoxic single doses of
APAP (GEO Accession number GSE5652). We identified gene
transcripts with similar patterns of change during APAP-induced
hepatotoxicity and, in a separate validation cohort, evaluated the
ability of these transcripts to discern APAP liver injury.
MATERIALS AND METHODS
STUDY DESIGN
The complete transcript data set used in our analyses has been
deposited at the Gene Expression Omnibus (GEO) Database
under Accession number GSE5652 and whole study design can
be obtained in a previously published study (Bushel et al., 2007).
Briefly, Male F344/N rats were divided into training and test sets.
For the training set, groups of four male rats, 12–14 weeks old,
not fasted before dosing, each received 0 (vehicle only), a subtoxic
dose (150 mg/kg) or two toxic doses (1500 or 2500 mg/kg) APAP
in 0.5% ethyl cellulose by oral gavage. For the test set, groups of
six male rats each received 0 (vehicle only), 150, or two toxic doses
(1500, or 2000 mg/kg) APAP in 0.5% ethyl cellulose by oral gavage.
The animals were killed at 6 or 24 h after dosing in both training
and test groups. Activities of ALT were measured in all rats at
study termination. mRNA was extracted from liver and blood for
microarray analysis.
EXTRACTION OF SIGNIFICANT GENES AND EXPRESSION SIGNATURES
Extracting Patterns and Identifying co-expressed Genes was
applied as previously described (Zhou et al., 2006; Chou et al.,
2007) to identify patterns among genes with significantly co-
regulated expression. Briefly, the extracted intensity data from
each array were preprocessed, which included array-based system-
atic variation normalization (Chou et al., 2005), profile-based dye
swap correction,and biological reference state alignment. Through
signal-to-noise ratio (SNR) evaluation applied to each correlation
local cluster, EPIG extracted a set of discrete gene expression pat-
terns. We denote each datum of log2 ratio as gij in a gene expression
profile, where i refers to a inter-group index from 1 to m, j is the
intra-group index from 1 to ni, m is the number of inter-groups,
and ni is the number of arrays in ith inter-group. To evaluate
such a profile, we calculate each intra-group average g¯i and sample
variance s2i . We define a gene expression profile’s signal as
S =
−
max
{
g¯i
}
, if min
{
g¯i
}
> 0
min
{
g¯i
}
, elseif max
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}
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where the sample variance
s2i =
ni∑
j
(
gij − g¯i
)2
ni − 1 . (3)
From Eqs 1 and 2, we define a profile’s SNR as
SNR = S
N
(4)
As can be seen, when m= 1, Eq. 3 is equivalent to a two sample
t -test, since by default the log2 pixel intensity ratio is the treated
against its control. Equation 3 includes the case for m> 1, i.e.,
multiple inter-groups (Chou et al., 2007).
Each pattern represented a set of co-regulated genes. EPIG used
the profile’s signal magnitude and SNR to identify genes with sig-
nificant expression changes, and categorized them within patterns
according to their correlation coefficient values.
Two-dimensional principle component analysis (PCA) and
hierarchical cluster analysis (HCA) were done using PARTEK. GO
categories were analyzed using Database for Annotation,Visualiza-
tion and Integrated Discovery (DAVID; Huang da et al., 2009a,b).
Such overrepresented categories represent biological “themes” of
a given list (Hawse et al., 2005). The fact that the blood and liver
tissues were from the same animals was not considered in the
analysis.
IDENTIFICATION OF TRANSCRIPTION FACTORS WITHIN AN
EXPRESSION PATTERN
Computational promoter analysis was done using Distant Reg-
ulatory Elements of co-regulated Genes (DiRE; Gotea and
Ovcharenko, 2008). Briefly, given a target set and a background
set of promoters, DiRE performs statistical tests based on a hyper-
geometric distribution aiming at identifying transcription fac-
tors (TFs) whose binding site signatures are significantly more
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enriched in the target set than in the background set. TFs were
identified according to scores of two parameters: occurrence and
importance. The “occurrence” represents the fraction of putative
regulatory elements (REs) that contain a particular transcription
binding sites (TFBS), while the “importance” is defined as the
product of the TF occurrence and its weight. In the current study,
co-regulated genes in each expression pattern were considered a
target set and the entire set of genes represented on the microarray
served as the background set.
RESULTS
Gene expression signatures were obtained from blood and liver
of both training and test sets of animals exposed to subtoxic
(150 mg/kg) and toxic (1500, 2000, or 2500 mg/kg) doses of APAP
hybridized with a time-matched vehicle control (Bushel et al.,
2007). Animals exposed to subtoxic dose (150 mg/kg) of APAP
showed neither ALT elevation nor histopathological changes in
liver at 6 and 24 h compared to vehicle treated animals. Training
set animals treated with toxic doses of APAP showed signifi-
cant ALT elevations (Table 1) and marked hepatocyte necrosis
and degeneration (data not shown) at 24 h. ALT elevation and
histopathological changes showed only minor differences among
the three toxic dose groups at 24 h, so all of these animals were
combined as one group for further analysis. In this study, there
was a good correlation between ALT elevation and histological
evidence of liver injury (Bushel et al., 2007).
IDENTIFICATION OF EXPRESSION SIGNATURES IN THE TRAINING
ANIMAL SET, 6 H POST DOSE
Expression profiles from both blood and liver in the training group
were analyzed for common expression patterns using EPIG at 6
and 24 h post APAP treatment using a p-value threshold of<0.001
for each pattern extraction. The significantly regulated genes were
selected in the current study based on criteria of three parame-
ters: correlation coefficient within a specific pattern (r ≥ 0.64), the
magnitude of change (log2 ratio of sample vs. reference>0.4), and
the SNR (SNR> 3).
Extracting Patterns and Identifying co-expressed Genes identi-
fied 3389 genes regulated in liver and/or blood among 10 expres-
sion patterns at 6 h post dose (Figures 1A,B). The expression
patterns in liver and blood are different in eight patterns (1, 2,
5–10) but similar in two patterns (3 and 4) that are of our inter-
est in the current study. Biological pathways and functions of the
genes in each pattern were analyzed using GO (Table S1 in Sup-
plementary Material). Genes from pattern 1 and 2 accounted for
most of the regulated genes (n= 1945) and these changes were not
mirrored in liver and blood. Genes in pattern 1 were up-regulated
in liver of which the most represented functions are DNA dam-
age response and signal transduction, cell cycle arrest, negative
regulation of cellular biosynthetic processes and positive regu-
lation of transcription; genes in pattern 2 were down-regulated
in liver and mainly involved in metabolic processes, including
carbohydrate, steroid, and lipid metabolism and mitochondrial
functions. Genes in pattern 5 and 6 were down-regulated in blood
but either up-regulated (pattern 5) or showed no change (pattern
6) in liver. Functions of these genes include RNA metabolism,
RNA translation and protein biosynthesis. Genes in pattern 7
and 8 showed dose-independent down-regulation in either liver
(pattern 7) or blood (pattern 8) but not both. Genes in pat-
tern 7 function in response to bacteria, lipid and cholesterol
synthesis, and genes in pattern 8 largely regulate cell prolifera-
tion. Genes in pattern 9 and 10 showed no changes in blood
but were changed in a dose-dependent way in liver. Genes in
pattern 9 were down-regulated by the subtoxic dose but up-
regulated by toxic doses. GO terms indicate they are largely related
to chaperones and endoplasmic reticulum. No significant GO
categories were identified from genes in pattern 10 that were
up-regulated by the non-toxic dose but down-regulated by toxic
dose.
There were two similarly co-regulated expression patterns, pat-
terns 3 and 4, in liver and blood involving 760 probes that were
all down-regulated in both tissues. Genes in pattern 3 (n= 271)
were down-regulated to the same extent in both tissues and
genes in pattern 4 (n= 489) were less down-regulated in liver
than in blood. Genes in pattern 3 are principally involved in
immune response, leukocyte activation, and chemotaxis. Genes
in pattern 4 are largely related to mitochondrial function and
oxidative phosphorylation (Tables S1 and S2 in Supplementary
Material).
VALIDATION IN THE TEST ANIMAL SET, 6 H POST DOSE
Expression signatures involving the 760 probes from pattern 3 and
4 identified in the training set of animals at 6 h were examined
in the test animal set. PCA and HCA revealed a good separa-
tion between animals receiving subtoxic and toxic doses of APAP
despite normal serum ALT at the time of sacrifice (Figure 2). How-
ever, one animal (marked with red arrows) receiving a toxic dose
of APAP was segregated with those animals receiving the subtoxic
dose. It is the same animal in Figures 2A,B.
Table 1 | ALT changes at 6 and 24h after APAP treatment.
Time Training (ALT, u/L) Test (ALT, u/L)
Subtoxica Toxicb Subtoxica Toxicc
6 h 76±13 (n=4) 77±14 (n=8) 53±20 (n=6) 63±22 (n=12)
24 h 47±3 (n=4) 8784±4948 (n=8) 53±7 (n=6) 3648±4890 (n=12)
aSubtoxic dose is 150 mg/kg that does not cause significant ALT elevation in comparison to vehicle only treatment; bToxic doses in training group are 1500 and
2500 mg/kg; cToxic doses in test group are 1500 and 2000 mg/kg.
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FIGURE 1 | Expression patterns at 6h after APAP treatment extracted by
EPIG for the training set animals. Pattern 1 is enlarged to clarify the displays
(A).The y -axis is the average log base 2 of the ratio values from the top six
profiles within the pattern. The ratio value is computed from the intensity
measurement for each gene in each treatment sample compared to the
average of the time-matched control for the sample. Zero at mid scale
represents no change in gene expression, above zero means up-regulation
and below zero means down-regulation. Two arrays were hybridized with Cy3
and Cy5 dye swap from one animal, so two dots represent one rat. Within a
single pattern from the left to the right: blood (solid dots) and liver (empty
dots); within the same tissue from left to right, subtoxic dose (triangle), and
toxic doses (circle). Other gene expression patterns are shown in (B). Gene
numbers for each pattern are shown in parentheses. Only pattern 3 and 4
contain genes that were similarly regulated in liver and blood.
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FIGURE 2 | Principle component analysis (PCA) and hierarchical cluster
analysis (HCA) of the test animal set at 6 h post dose.The 760 probes
identified in the training animal as co-regulated in liver and blood at 6 h
(patterns 3 and 4 in Figure 1B) reasonably distinguished the animals receiving
the subtoxic dose from those receiving toxic doses. Cy3 and Cy5 array results
were averaged for each rat so each symbol represents a single animal. (A)
Liver PCA result; (B) Blood PCA result; (C) Liver HCA result; (D). Blood HCA
result. For HCA, samples were grouped by Euclidean distance and average
linkage. Legends for (A,B): circle, subtoxic; Triangle, toxic. Legends for (C,D)
Red, subtoxic; Blue, toxic.
IDENTIFICATION OF EXPRESSION SIGNATURES IN THE TRAINING
ANIMAL SET, 24 H POST DOSE
A total of 3984 genes were identified at 24 h as being either up or
down-regulated in either liver or blood among seven expression
patterns extracted by EPIG shown in Figure 3.
The regulated genes in each pattern were also subjected to GO
analysis to identify enriched biological functions and pathways.
Genes from pattern 1 and 2 showed significant changes in liver
that were not accompanied by parallel changes in blood. These
two patterns accounted for about 84% (3347) of all the regulated
genes identified. Genes in pattern 1 were up-regulated in liver and
are related to cell cycle regulation, cell death, and DNA repair;
genes in pattern 2 were down-regulated in liver and are primar-
ily related to oxidation and reduction, mitochondrial functions,
CYPs, and metabolic processes, including steroid, cholesterol, and
lipid metabolism. Pattern 5 and 6 showed changes in regulation
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FIGURE 3 | Expression patterns in the training animal set at 24h after
APAP treatment extracted by EPIG.The axes and symbols are identical to
those in Figure 1A. Gene numbers for each pattern are shown in parentheses.
Patterns 3 and 4 contained genes undergo similar regulation in liver and blood.
of specific genes in both liver and blood during APAP hepato-
toxicity, but the direction of regulation was opposite in the two
tissues. Genes in pattern 5 were up-regulated in blood but down-
regulated in liver. These genes are related to microsome and cell
fraction; genes in pattern 6 were down-regulated in blood but
slightly up-regulated in liver with main functions in protein cata-
bolic processes. Genes in pattern 7 were up-regulated by toxic dose
of APAP only in blood. These genes are involved in different kinds
of immune processes and cell death.
A total of 185 probes were co-regulated in a similar fashion in
liver and blood (patterns 3 and 4). GO analysis indicated the up-
regulated genes (n= 106) in pattern 3 are principally related to
inflammation processes and the down-regulated genes (n= 79)
in pattern 4 play important roles in mitochondrial function
(Tables S3 and S4 in Supplementary Material).
VALIDATION IN THE TEST ANIMAL SET, 24 H POST DOSE
We assessed expression changes in the 185 probes from patterns
3 and 4 in the test animal set to classify APAP exposure and liver
injury (Figure 4). PCA and HCA indicated that classification of
exposure levels by the gene set from either liver or blood at 24 h,
when toxicity was evident, was very poor when binary categories,
subtoxic and toxic, were applied. About half of the animals that
received toxic doses were segregated together with subtoxic dosed
animals. Further analysis of ALT levels in these animals showed no
elevation compared to vehicle or subtoxic dose treated animals,
indicating no liver injury occurred despite administration of toxic
doses of APAP. Very interestingly, the gene set, when used to clas-
sify liver injury evaluated by ALT elevation, was able to correctly
separate animals with no liver injury (ALT< 100) from those with
liver injury (ALT ranging from 200 to 12,000) despite the APAP
exposure doses. The only one misclassified from the group with
liver injury into the group without injury by blood expression sig-
nature was dosed with 1500 mg/kg of APAP and had an ALT level
of 3380 U/L (marked with a red arrow). The same animal (also
marked with a red arrow) is correctly classified by liver expression
signature.
TRANSCRIPTION FACTOR IDENTIFICATION FOR CO-REGULATED GENES
UPON LIVER INJURY AT 6 AND 24 H
Transcription factors most implicated in the co-regulated genes
in liver and blood within an expression pattern (Figure 1B, pat-
terns 3 and 4; Figure 3, patterns 3 and 4) were identified using
DiRE (Gotea and Ovcharenko, 2008). The top five TFs implicated
at each expression pattern at 6 and 24 h are shown in Table 2 with
occurrence rates and importance scores.
COMPARISON OF THE 6 AND 24 H EXPRESSION PROFILES
We next compared the gene sets identified as having similar reg-
ulation in liver and blood at 6 or 24 h. Only 38 of the total 945
genes identified were common to both gene sets (Table S6 in
Supplementary Material); GO category analysis of these 38 genes
indicated enrichment of genes involved in mitochondrial func-
tion and regulation of lymphocyte and leukocyte activation (Table
S5 in Supplementary Material). The expression signature consist-
ing of only these 38 genes was able to separate the test animals
receiving toxic and subtoxic APAP doses at 6 h or animals with or
without liver injury at 24 h post dose, with the same performance
efficiency as the parent gene sets (760 or 185) in both liver and
blood.
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FIGURE 4 | Principle component analysis (PCA) and hierarchical cluster
analysis (HCA) of test animal set at 24h post dose.The 185 probes
identified to be co-regulated in liver and blood in the training animal set
(patterns 3 and 4 in Figure 3) generally separated animals without liver injury
[ALT<100; circle and diamond in (A,B); red and blue in (C,D)] from those with
liver injury [ALT 200-12, 000; triangle in (A,B); green in (C,D)] but had a poor
classification of exposure levels, categorized as subtoxic dose [circle in (A,B),
red in (A,B)] and toxic dose [diamond and triangle in (A,B), blue and green in
(C,D)] in both liver (A,B) and blood (A,B). (A) Liver PCA result; (B) Blood PCA
result; (C). Liver HCA result; (D). Blood HCA result. For HCA, samples were
grouped by Euclidean distance and average linkage. Legends for (A,B): circle,
subtoxic dose; diamond, toxic dose without liver injury; Triangle, toxic dose
with liver injury. Legends for (A,B): red, subtoxic dose; Blue, toxic dose
without liver injury; Green, toxic dose with liver injury.
DISCUSSION
Application of blood as a surrogate tissue to extract genomic
indicators for cross tissue prediction of target organ injury has
been reported in several studies (Bushel et al., 2007; Lobenhofer
et al., 2008; Huang et al., 2010; Umbright et al., 2011). Blood
transcriptomic changes have been shown to precede appearance
of traditional markers of tissue injury and it has been suggested
that blood toxicogenomics might provide novel biomarkers to
identify patients who will develop severe liver toxicity after tak-
ing overdoses of APAP (Cui and Paules, 2010). The mechanisms
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Table 2 |Transcription factors for co-regulated genes from pattern 3 and 4 at 6 and 24h post APAP treatment.
Time Pattern 3 Pattern 4
TF Occurrence Importance TF Occurrence Importance
6 h ISRE 0.1584 0.62995 FOXP3 0.0738 0.32975
PPARA 0.1584 0.35743 ZIC2 0.0902 0.23274
40820 0.1089 0.33558 STAT1 0.1475 0.225
ZIC1 0.1188 0.29926 HMEF2 0.0738 0.21071
NCX 0.099 0.20854 NRSF 0.0738 0.16368
24 h P53 0.1111 0.27778 TBP 0.1333 0.36996
HNF3 0.1111 0.23153 TEL2 0.1 0.26987
HFH1 0.1111 0.23104 MYC 0.0667 0.20898
NF1 0.1481 0.16037 SREBP1 0.1667 0.17792
ETS1 0.1111 0.08964 STAT6 0.1333 0.16233
underlying changes in blood transcriptome during APAP hepato-
toxicity are not known. It has been proposed “that the circulating
blood cells monitor the physiological state of the organism and
alter their transcriptome in response to this surveillance.” (Bur-
czynski and Dorner, 2006). Hence, the changes occurring in the
blood transcriptome may reflect a reaction to hepatotoxicity of
APAP. On the other hand, changes occurring in whole blood tran-
scriptome observed during APAP toxicity in humans have been
linked to known mechanisms of APAP toxicity in the liver and it
has therefore been suggested that analysis of whole blood tran-
scriptome may provide insight into mechanisms that underlie
hepatotoxicity (Fannin et al., 2011). This is possible since lym-
phocytes contain many of the cofactors and enzymes implicated
in mechanisms of APAP hepatotoxicity (Dey et al., 2005; Hannon-
Fletcher and Barnett, 2008; Dhillon et al., 2011) and APAP-induced
cytoxicity may account for a fall in circulating lymphocyte counts
during APAP hepatotoxicity in rodents (Yamaura et al., 2002; Mas-
son et al., 2007). The extent to which changes in liver transcriptome
are mirrored in blood during APAP toxicity has not been previ-
ously reported. We addressed this question using EPIG and tox-
icogenomics data provided by prior rat studies of APAP-induced
liver injury (Bushel et al., 2007).
We were able to successfully identify expression patterns show-
ing similar expression changes in liver and blood in the train-
ing animal set at 6 and 24 h (Figures 1 and 3). GO analysis
of biological functions of these genes within each expression
patterns supported a mechanistic link to APAP hepatotoxicity.
At 6 h, the genes co-regulated in liver and blood were involved
in mitochondrial function, including oxidative phosphorylation
(Figure 1B, pattern 4). Down-regulation of oxidative phospho-
rylation genes was more pronounced in blood than liver, sug-
gesting that impairment of oxidative phosphorylation may occur
earlier in blood than liver. This may reflect higher exposure to
blood cells relative to liver, or increased sensitivity of specific
cell types in blood. There was also coordinate down-regulation
at 6 h of genes involved in immune function and inflamma-
tion (Figure 1B, pattern 3). We speculate that this may some-
how represent an adaptive response prior to overt liver injury.
At 24 h, biological pathways including inflammation processes
and mitochondrial function were also identified among the co-
regulated genes in liver and blood, showing up-regulation of
inflammation processes (Figure 3, pattern 3) and down-regulation
of mitochondrial function (Figure 3, pattern 4). The identified
pathways at 6 and 24 h are consistent with the accepted roles of
mitochondria and inflammation in APAP-induced hepatotoxicity
(Lee, 2003; Jaeschke and Bajt, 2006; Larson, 2007). Although these
observations are consistent with similar mechanisms of action in
liver and blood, caution is appropriate in the interpretation of our
data since the pathways identified could be operative by multiple
mechanisms.
Application of the extracted expression signatures in a separate
test set of animals yielded interesting results. Bushel et al. (2007)
reported the utility of blood gene expression data to predict expo-
sure to APAP in the same rat data set. Classifiers from multiple
prediction algorithms were applied to predict the APAP exposure
levels divided into nonsubtoxic and toxic without considering the
duration of exposure with high accuracy (88.9–95.8%). In the cur-
rent study, at 6 h when no obvious liver injury was observed, both
liver and blood expression signatures had very good classifica-
tion of APAP exposure levels based on a binary category: subtoxic
vs. toxic (Kerns and Bushel, 2012). Huang et al. (2010) explored
the use of rat blood gene expression data to predict liver necro-
sis. DILI was defined as a binary response (no necrosis vs. some
observable sign of necrosis) without considering the dose and/or
time of exposure. From the various, highly accurate predictors, 10
gene-probes occurred most often.
Changes in gene expression at 6 h may reflect an early adaptive
mechanism related to exposure levels but less related to actual liver
injury. Neither liver nor blood expression signature had a good
APAP exposure classification at 24 h based on the same binary
category. However, when liver injury measured as ALT elevation
was used as endpoint for anchoring to a phenotype, both liver and
blood expression signatures yielded very good classifications.
Liver injury classification by expression signatures was not
able to be performed at 6 h because of lack of histological evi-
dence and ALT elevation in all animals sacrificed at this time
point. An interesting observation was one rat treated with a toxic
dose of APAP co-segregated at 6 h with those animals receiving
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subtoxic doses of APAP (Figures 2A,B). We speculate that this
animal might not have developed overt liver toxicity; since this
animal was sacrificed at 6 h, there was no way to determine
this. This hypothesis could be tested in a new study by assess-
ing the transcript profile in blood at 6 h but allowing the ani-
mals to live to 24 h post dose when responder status could be
determined.
In spite of similar processes and functions being identified
among the co-regulated gene patterns at 6 and 24 h, there were
just 38 genes present in both gene sets. Among the 38 genes, 14
genes were down-regulated at 6 h but up-regulated at 24 h, and
24 genes were down-regulated at both 6 and 24 h. We found that
expression signatures using just these 38 genes had similar efficacy
to the larger gene sets in distinguishing those animals receiving
toxic and subtoxic doses at 6 h. In addition, this limited gene set
was also capable of separating animals at 24 h based on the extent
of toxicity as reflected in ALT values. Not surprisingly, 11 of the 38
genes are closely related to mitochondrial function (Abcd3, Mccc1,
Mosc2, Sdha, and Sdhd) and immune response (Ccl5, Cd1d1, Fas,
Il1b, and Lat ).
Change in the expression of a group of genes is often the result
of activation or inactivation of TFs in response to endogenous or
extraneous stress. We therefore analyzed the co-regulated genes
to identify the top 10 implicated TFs at 6 and 24 h. In some
cases, the identified TFs may provide mechanistic insight into
APAP toxicity. Activation of p53 at 24 h may suggest that DNA
damage is involved in the final stages in APAP-induced liver and
blood cell injury. TATA-box binding protein (TBP) plays a cru-
cial role in transcription initiation of RNA polymerases (Muller
et al., 2010; Tora and Timmers, 2010) which may stimulate pro-
tein synthesis necessary for injury repair. Interferon-stimulated
response element (ISRE) and PPARα are two TFs with the high-
est importance score identified by DiRE at 6 h. ISRE has not been
reported to be directly related to APAP hepatotoxicity. However, it
plays important roles in regulation of interferon-induced gene
regulation (Wesoly et al., 2007), which has been implicated in
mechanisms of APAP-induced liver injury (Ishida et al., 2002;
Ghaffari et al., 2011). The suppression of PPARα activation has
also been reported as a contributing mechanism of APAP-induced
hepatotoxicity (Chen et al., 2009).
In conclusion, similar expression changes occur in a subset of
genes in blood and liver during APAP-induced liver injury and
after treatment with toxic doses of APAP before onset of overt tox-
icity. Although the genes that demonstrated coordinate regulation
between the tissues represent a small fraction of the total affected
genes, the pathways, and functions linked to these genes may sup-
port the idea that transcriptomic analysis of blood can provide
mechanistic insight into DILI. However, a true mechanistic link
between tissues remains to be demonstrated. The ability of the
transcript signatures to distinguish those receiving the identical
doses but demonstrating variability in susceptibility to the toxicity
supports other data suggesting that blood toxicogenomics might
provide a useful avenue to predicting susceptibility to liver toxicity
in the clinic.
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